CCMP In Talks to Buy Medpace in $500-$600M Deal
CCMP Capital Advisors is in talks to buy Medpace, a Cincinnati-based contract research organization, two sources said. The deal is valued at roughly $500 to $600 million, one person says. Founded in 1992, Medpace provides clinical drug development services for the pharmaceutical and biotech industries. It employs about 1,000 people globally. The sale of Medpace was not an auction, one banker says. Instead, CCMP has been in exclusive talks to buy Medpace, the source says.
20 May 2011•1 min read
